Apoptosis

, Volume 12, Issue 9, pp 1611–1622 | Cite as

Epidermal growth factor rescues trophoblast apoptosis induced by reactive oxygen species

  • Sarah J. Moll
  • Carolyn J. P. Jones
  • Ian P. Crocker
  • Philip N. Baker
  • Alexander E. P. Heazell
Original Paper

Abstract

Pre-eclampsia and intrauterine growth restriction are associated with increased apoptosis of placental villous trophoblast. This may result from placental hypoperfusion, leading to the generation of reactive oxygen species (ROS). Apoptosis can be induced in villous trophoblast following exposure to oxidative stress. Epidermal growth factor (EGF) reduces trophoblast apoptosis resulting from exposure to hypoxia. We hypothesised that exposure to hydrogen peroxide, a potent generator of ROS, would induce apoptosis in term placental villous explants and that this could be reduced by treatment with EGF. Placental explants were taken from normal term pregnancies and exposed to increasing doses of hydrogen peroxide (0–1,000 μM) or to a combination of increasing doses of hydrogen peroxide and EGF (0–100 ng/ml) for either 6 or 48 h. Apoptosis was assessed by TUNEL, proliferation by Ki-67 immunostaining, necrosis by lactate dehydrogenase activity and trophoblast differentiation by human chorionic gonadotrophin (hCG) secretion in conditioned culture media. Immunoperoxidase staining was performed to identify phosphorylated-AKT (p-AKT) and phosphorylated-PI3 kinase (p-PI3k). Exposure to 1,000 μM hydrogen peroxide for 48 h induced apoptosis in placental explants. The increase in TUNEL positive nuclei predominantly localised to syncytiotrophoblast. The amount of apoptosis was reduced to control levels by treatment with 10 and 100 ng/ml EGF. Proliferation of cytotrophoblasts within villous explants was significantly reduced following exposure to 1,000 μM hydrogen peroxide, this was restored to control levels by simultaneous treatment with 10 or 100 ng/ml EGF. Neither exposure to hydrogen peroxide or EGF altered the amount of necrosis. There was increased immunostaining for pPI3K following treatment with EGF. This study shows that apoptosis may be induced in villous trophoblast following exposure to ROS, and demonstrates the anti-apoptotic effect of EGF in trophoblast, the maintenance of which is essential for normal pregnancy.

Keywords

Placenta Villous trophoblast Apoptosis Reactive oxygen species Epidermal growth factor 

References

  1. 1.
    Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A (1994) A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br J Obstet Gynaecol 101(8):669–674PubMedGoogle Scholar
  2. 2.
    Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ (2000) Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 157(6):2111–2122PubMedGoogle Scholar
  3. 3.
    Huppertz B, Frank HG, Reister F, Kingdom J, Korr H, Kaufmann P (1999) Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest 79(12):1687–1702PubMedGoogle Scholar
  4. 4.
    Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA (2000) Placental apoptosis in preeclampsia. Obstet Gynecol 96(2):271–276PubMedCrossRefGoogle Scholar
  5. 5.
    Leung DN, Smith SC, To KF, Sahota DS, Baker PN (2001) Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 184(6):1249–1250PubMedCrossRefGoogle Scholar
  6. 6.
    Heazell AE, Moll SJ, Jones CJ, Baker PN, Crocker IP (2006) Formation of syncytial knots is increased by hyperoxia, hypoxia and reactive oxygen species. Placenta 28(Supplement 1):S33–S40PubMedGoogle Scholar
  7. 7.
    Smith SC, Baker PN, Symonds EM (1997) Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 177(6):1395–1401PubMedCrossRefGoogle Scholar
  8. 8.
    Levy R, Smith SD, Yusuf K, Huettner PC, Kraus FT, Sadovsky Y, Nelson DM (2002) Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol 186(5):1056–1061PubMedCrossRefGoogle Scholar
  9. 9.
    Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T (2002) Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 186(1):158–166PubMedCrossRefGoogle Scholar
  10. 10.
    Johansen M, Redman CW, Wilkins T, Sargent IL (1999) Trophoblast deportation in human pregnancy—its relevance for pre-eclampsia. Placenta 20(7):531–539PubMedCrossRefGoogle Scholar
  11. 11.
    Levy R, Smith SD, Chandler K, Sadovsky Y, Nelson DM (2000) Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol 278(5):C982–C988PubMedGoogle Scholar
  12. 12.
    Hung TH, Skepper JN, Charnock-Jones DS, Burton GJ (2002) Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 90(12):1274–1281PubMedCrossRefGoogle Scholar
  13. 13.
    Fadeel B, Orrenius S (2005) Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med 258(6):479–517PubMedCrossRefGoogle Scholar
  14. 14.
    Levy R, Nelson DM (2000) To be, or not to be, that is the question. Apoptosis in human trophoblast. Placenta 21(1):1–13PubMedCrossRefGoogle Scholar
  15. 15.
    Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ (1994) Cytotoxicity of tumour necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 15(8):819–835PubMedCrossRefGoogle Scholar
  16. 16.
    Crocker IP, Tansinda DM, Jones CJ, Baker PN (2004) The influence of oxygen and tumor necrosis factor-alpha on the cellular kinetics of term placental villous explants in culture. J Histochem Cytochem 52(6):749–757PubMedCrossRefGoogle Scholar
  17. 17.
    Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC (1992) Cell death and control of cell survival in the oligodendrocyte lineage. Cell, 70(1):31–46PubMedCrossRefGoogle Scholar
  18. 18.
    Raff MC (1992) Social controls on cell survival and cell death. Nature 356(6368):397–400PubMedCrossRefGoogle Scholar
  19. 19.
    Smith S, Francis R, Guilbert L, Baker PN (2002) Growth factor rescue of cytokine mediated trophoblast apoptosis. Placenta 23(4):322–330PubMedCrossRefGoogle Scholar
  20. 20.
    Garcia-Lloret MI, Yui J, Winkler-Lowen B, Guilbert LJ (1996) Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J Cell Physiol 167(2):324–332PubMedCrossRefGoogle Scholar
  21. 21.
    Payne SG, Brindley DN, Guilbert LJ (1999) Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts. J Cell Physiol 180(2):263–270PubMedCrossRefGoogle Scholar
  22. 22.
    Morrish DW, Bhardwaj D, Dabbagh LK, Marusyk H, Siy O (1987) Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta. J Clin Endocrinol Metab 65(6):1282–1290PubMedGoogle Scholar
  23. 23.
    Anteby EY, Greenfield C, Natanson-Yaron S, Goldman-Wohl D, Hamani Y, Khudyak V, Ariel I, Yagel S (2004) Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9. Mol Hum Reprod 10(4):229–235PubMedCrossRefGoogle Scholar
  24. 24.
    Muhlhauser J, Crescimanno C, Kaufmann P, Hofler H, Zaccheo D, Castellucci M (1993) Differentiation and proliferation patterns in human trophoblast revealed by c-erbB-2 oncogene product and EGF-R. J Histochem Cytochem 41(2):165–173PubMedGoogle Scholar
  25. 25.
    Bulmer JN, Thrower S, Wells M (1989) Expression of epidermal growth factor receptor and transferrin receptor by human trophoblast populations. Am J Reprod Immunol 21(3–4):87–93PubMedGoogle Scholar
  26. 26.
    Hofmann GE, Drews MR, Scott RT Jr, Navot D, Heller D, Deligdisch L (1992) Epidermal growth factor and its receptor in human implantation trophoblast: immunohistochemical evidence for autocrine/paracrine function. J Clin Endocrinol Metab 74(5):981–988PubMedCrossRefGoogle Scholar
  27. 27.
    Ladines-Llave CA, Maruo T, Manalo AS, Mochizuki M (1991) Cytologic localization of epidermal growth factor and its receptor in developing human placenta varies over the course of pregnancy. Am J Obstet Gynecol 165(5 Pt 1):1377–1382PubMedGoogle Scholar
  28. 28.
    Toth FD, Aboagye-Mathiesen G, Nemes J, Liu X, Andirko I, Hager H, Zdravkovic M, Szabo J, Kiss J, Aranyosi J, Ebbesen P (1997) Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells. Virology 229(2):400–414PubMedCrossRefGoogle Scholar
  29. 29.
    Tavare JM, Holmes CH (1989) Differential expression of the receptors for epidermal growth factor and insulin in the developing human placenta. Cell Signal 1(1):55–64PubMedCrossRefGoogle Scholar
  30. 30.
    Filla MS, Zhang CX, Kaul KL (1993) A potential transforming growth factor alpha/epidermal growth factor receptor autocrine circuit in placental cytotrophoblasts. Cell Growth Differ 4(5):387–393PubMedGoogle Scholar
  31. 31.
    Lindqvist P, Grennert L, Marsal K (1999) Epidermal growth factor in maternal urine–a predictor of intrauterine growth restriction? Early Hum Dev 56(2–3):143–150PubMedCrossRefGoogle Scholar
  32. 32.
    Kamei Y, Tsutsumi O, Yamakawa A, Oka Y, Taketani Y, Imaki J (1999) Maternal epidermal growth factor deficiency causes fetal hypoglycemia and intrauterine growth retardation in mice: possible involvement of placental glucose transporter GLUT3 expression. Endocrinology 140(9):4236–4243PubMedCrossRefGoogle Scholar
  33. 33.
    Maruo T, Matsuo H, Murata K, Mochizuki M (1992) Gestational age-dependent dual action of epidermal growth factor on human placenta early in gestation. J Clin Endocrinol Metab 75(5):1362–1367PubMedCrossRefGoogle Scholar
  34. 34.
    Soleymanlou N, Jurisica I, Nevo O, Ietta F, Zhang X, Zamudio S, Post M, Caniggia I (2005) Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab 90(7):4299–4308. Epub 2005 Apr 19PubMedCrossRefGoogle Scholar
  35. 35.
    Halliwell B, Clement MV, Long LH (2000) Hydrogen peroxide in the human body. FEBS Lett 486(1):10–13PubMedCrossRefGoogle Scholar
  36. 36.
    Crocker IP, Daayana SL, Baker PN (2004) An image analysis technique for the investigation of human placental morphology in pre-eclampsia and intrauterine growth restriction. J Soc Gynecol Invest 11(8):545–552CrossRefGoogle Scholar
  37. 37.
    Siman CM, Sibley CP, Jones CJ, Turner MA, Greenwood SL (2001) The functional regeneration of syncytiotrophoblast in cultured explants of term placenta. Am J Physiol Regul Integr Comp Physiol 280(4):R1116–R1122PubMedGoogle Scholar
  38. 38.
    Crocker IP, Tansinda DM, Baker PN (2004) Altered cell kinetics in cultured placental villous explants in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. J Pathol 204(1):11–18PubMedCrossRefGoogle Scholar
  39. 39.
    Maddox PH, Jenkins D (1987) 3-Aminopropyltriethoxysilane (APES): a new advance in section adhesion. J Clin Pathol 40(10):1256–1257PubMedCrossRefGoogle Scholar
  40. 40.
    Jones CJ, Mosley SM, Jeffrey IJ, Stoddart RW (1987) Elimination of the non-specific binding of avidin to tissue sections. Histochem J 19(5):264–268PubMedCrossRefGoogle Scholar
  41. 41.
    Cheung AN, Ngan HY, Collins RJ, Wong YL (1994) Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen. J Clin Pathol 47(7):601–604PubMedCrossRefGoogle Scholar
  42. 42.
    Jinno Y, Merlino GT, Pastan I (1988) A novel effect of EGF on mRNA stability. Nucleic Acids Res 16(11):4957–4966PubMedCrossRefGoogle Scholar
  43. 43.
    Burdon RH (1995) Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med 18(4):775–794PubMedCrossRefGoogle Scholar
  44. 44.
    Castellucci M, Kaufmann P (2006) Basic structure of the villous trees. In: Benirschke K, Kaufmann P (eds) Pathology of the placenta. Springer, New York, pp 50–120CrossRefGoogle Scholar
  45. 45.
    Levy R, Smith SD, Chandler K, Sadovsky Y, Nelson DM (2000) Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol 278(5):C982–C988PubMedGoogle Scholar
  46. 46.
    Ka H, Hunt JS (2003) Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol 163(2):413–422PubMedGoogle Scholar
  47. 47.
    Fulop V, Mok SC, Genest DR, Gati I, Doszpod J, Berkowitz RS (1998) p53, p21, Rb and mdm2 oncoproteins. Expression in normal placenta, partial and complete mole, and choriocarcinoma. J Reprod Med 43(2):119–127PubMedGoogle Scholar
  48. 48.
    Toki T, Horiuchi A, Ichikawa N, Mori A, Nikaido T, Fujii S (1999) Inverse relationship between apoptosis and Bcl-2 expression in syncytiotrophoblast and fibrin-type fibrinoid in early gestation. Mol Hum Reprod 5(3):246–251PubMedCrossRefGoogle Scholar
  49. 49.
    Yui J, Garcia-Lloret M, Brown AJ, Berdan RC, Morrish DW, Wegmann TG, Guilbert LJ (1994) Functional, long-term cultures of human term trophoblasts purified by column-elimination of CD9 expressing cells. Placenta 15(3):231–246PubMedGoogle Scholar
  50. 50.
    Kliman HJ, Nestler JE, Sermasi E, Sanger JM, Strauss JF 3rd (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology 118(4):1567–1582PubMedCrossRefGoogle Scholar
  51. 51.
    Crocker IP, Barratt S, Kaur M, Baker PN (2001) The in-vitro characterization of induced apoptosis in placental cytotrophoblasts and syncytiotrophoblasts. Placenta 22(10):822–830PubMedCrossRefGoogle Scholar
  52. 52.
    Sakuragi N, Matsuo H, Coukos G, Furth EE, Bronner MP, VanArsdale CM, Krajewsky S, Reed JC, Strauss JF 3rd (1994) Differentiation-dependent expression of the BCL-2 proto-oncogene in the human trophoblast lineage. J Soc Gynecol Investig 1(2):164–172PubMedGoogle Scholar
  53. 53.
    Kawamata T, Yamaguchi T, Shin-ya K, Hori T (2003) Divergence in signaling pathways involved in promotion of cell viability mediated by bFGF, NGF, and EGF in PC12 cells. Neurochem Res 28(8):1221–1225PubMedCrossRefGoogle Scholar
  54. 54.
    Qiu Q, Yang M, Tsang BK, Gruslin A (2004) EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways. Reproduction 128(3):355–363PubMedCrossRefGoogle Scholar
  55. 55.
    Johnstone ED, Sibley CP, Lowen B, Guilbert LJ (2005) Epidermal growth factor stimulation of trophoblast differentiation requires MAPK11/14 (p38 MAP kinase) activation. Biol Reprod 73(6):1282–1288PubMedCrossRefGoogle Scholar
  56. 56.
    Perkins J, St John J, Ahmed A (2002) Modulation of trophoblast cell death by oxygen and EGF. Mol Med 8(12):847–856PubMedGoogle Scholar
  57. 57.
    Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, Greenberg ME (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91(2):231–241PubMedCrossRefGoogle Scholar
  58. 58.
    Ho S, Winkler-Lowen B, Morrish DW, Dakour J, Li H, Guilbert LJ (1999) The role of Bcl-2 expression in EGF inhibition of TNF-alpha/IFN-gamma-induced villous trophoblast apoptosis. Placenta 20(5–6):423–430PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Sarah J. Moll
    • 1
  • Carolyn J. P. Jones
    • 1
  • Ian P. Crocker
    • 1
  • Philip N. Baker
    • 1
  • Alexander E. P. Heazell
    • 1
  1. 1.Division of Human Development, St Mary’s HospitalUniversity of ManchesterManchesterUK

Personalised recommendations